Video courtesy of James Lewis, MD

Proprietary Sterile Injectable Compounded Formulations

Dropless Formulations from Imprimis:

  • Are quality sterile injectable compounded medications† for use in ocular surgery
  • Were invented by ophthalmologists and pharmacists for unmet medical needs
  • Use patent-pending technologies that uniquely allow for the combination of drugs
brought to you by imprimis
Tri-Moxi

Triamcinolone acetonide and moxifloxacin hydrochloride

Tri-Moxi-Vanc

Triamcinolone acetonide, moxifloxacin hydrochloride and vancomycin

Lyophilized Mydriatics

Ophthalmologists currently using Dropless formulations believe the optimal location for the injection would be the vitreous due to the depot effect. This is achieved by entering through the zonules, or “transzonularly.”

Learn more about the transzonular technique and browse through multiple surgical videos in our online educational portal.

Dropless Availability

Imprimis’ compounded formulations are currently shipping to the highlighted states and territories. Be sure to check back frequently for availability updates in additional locations.

“Dropless Providers” -- ophthalmic surgeons currently offering Dropless therapy in their practice(s) -- are also shown here. Get on the map today!

Learn about placing an Order »
availability map
Become a Dropless Provider!

95% of cataract surgeons surveyed would prefer dropless therapy

Upcoming Events

OSN New York

NOV 14 - NOV 16 | New York, New York

Visit us at booth #10. Event details coming soon!

Event Website

Millennial Eye (ME Live)

NOV 21 - NOV 23 | Austin, Texas

Event details coming soon!

Event Website

Hawaiian Eye Annual Meeting

JAN 17 - JAN 23 | Maui, Hawaii

Visit us at booth #111. Event details coming soon!

Event Website

Interested in seeing us at one of these events?

Join Us! »